Testing sentinel lymph node surgery for early ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a way to check for cancer spread in the lymph nodes of the pelvis during surgery for early-stage ovarian cancer. It uses a special dye and tracer to find the first lymph node that drains from the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have or may have ovarian cancer that is in an early stage (FIGO I or II), meaning it hasn't spread far.
- You can have surgery to remove the tumor and check nearby lymph nodes.
- You have not had previous surgeries on major blood vessels or lymph nodes in the pelvis or belly.
- You are not allergic to the special dye or tracer used during the procedure.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a technique that uses a special dye to find the first lymph nodes where ovarian cancer might spread. It aims to help doctors remove only those sentinel nodes during surgery instead of removing many nodes, which could lead to fewer side effects.
This study tests a technique to find the first lymph nodes that might contain cancer cells during surgery for early-stage ovarian cancer. It aims to see if this method can help doctors remove fewer lymph nodes while still getting important information.
This study checks whether doctors can find the first lymph node(s) where ovarian cancer may spread using two dyes (a radioactive tracer and a green dye). It may help surgeons do more precise staging and treatment planning.
This trial studies whether taking a sample from the sentinel lymph node during surgery can help with staging early ovarian cancer. It may help doctors find spread to lymph nodes more accurately while limiting unnecessary lymph node removal in some cases.
This study is testing a blue dye called Patent Blue to see if it can help surgeons find sentinel lymph nodes (the first nodes cancer might spread to) during surgery for early-stage ovarian cancer. The goal is to reduce the need for more extensive lymph node removal, possibly leading to fewer side effects.
This trial studies whether removing (dissecting) lymph nodes during surgery can improve care for people with early-stage ovarian cancer that still needs chemotherapy. You may be eligible if you have certain ovarian cancer types and your scans and surgery do not show clearly suspicious lymph nodes.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.